MeredithLaRoseMD

Physician

Dr. LaRose is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 2018 - 2021
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2018

PubMed

62 citations
Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma
Christopher M. Wright, Michael J. LaRiviere, Jonathan Baron, C.Z. Uche, Ying Xiao
International Journal of Radiation Oncology, Biology, Physics. 2020-09-01
25 citations
Macrophage Migration Inhibitory Factor Promotes Clearance of Pneumococcal Colonization
Rituparna Das, Meredith I. LaRose, Christopher B. Hergott, Lin Leng, Richard Bucala
Journal of Immunology. 2014-07-15
21 citations
Macrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic Immunomodulation
Jeffrey N. Weiser, Aoife M. Roche, Christopher B. Hergott, Meredith I. LaRose, Tarah M. Connolly
The Journal of Infectious Diseases. 2015-05-05

Abstracts/Posters

Hospitalization Patterns with Commercial CAR T-Cell Therapy: A Single Institution Experience
Meredith I LaRose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Use of Bendamustine for Lymphodepletion before Tisagenlecleucel (anti-CD19 CAR T cells) for Aggressive B-Cell Lymphomas
Meredith I LaRose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019